In the first video dispatch from the National Association of Chain Drug Stores Annual Meeting, Drug Store News talks to Innovation’s Doyle Jensen about how the company is looking to use automation to improve patient care in the pharmacy.
Procter & Gamble is holding talks with Trian Fund Management, which has a $3.5 billion stake in the company, about the future of its brands, the P&G CEO David Taylor confirmed to CNBC. Taylor called the talks “constructive” and noted, "We are willing to engage. We want to be better.” Trian has been increasing its stake in P&G and the company looks to cut costs by some $10 billion, the report said. (CNBC)
The National Community Pharmacists Association has sent its comments on to the Centers for Medicare and Medicaid Services regarding the agency’s recently proposed changes to how direct and indirect remuneration fees are reported.
Since 2011, 68 novel therapies have been approved globally across 22 cancer indications. The QunitilesIMS Institute report looks at what technological advances and development trends have made this possible, as well as their cost.
Under the acquisition, MedCart will continue to operate as it did before, but as a new business unit under Albertsons’ pharmacy team structure, with the leadership team reporting directly to Albertsons group VP pharmacy operations, Dain Rusik.
Mallinckrodt, in an effort to focus more on branded products, is looking for a buyer for its generics division who could pay as much as $2 billion for the business, according to a Reuters report. Reuters noted that the company’s generics sales have dropped roughly 18% between 2015 and 2016 — a period during which its branded specialty sales grew by some 40%, partially through acquisitions. (Reuters)
With AmazonFresh Pickup, which allows Amazon Prime members to order groceries online and pick them up in as little as 15 minutes, has moved out of the pilot stages and is now available to a wider range of Amazon Prime customers.
Appearing before the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration and Related Agencies, Food and Drug administration commissioner Dr. Scott Gottlieb outlined plans to address pressing generics industry issues.